Výsledky vyhledávání - "Hans-Jochen Jochen Weber"

Siremadlin monotherapy and in combination with donor lymphocyte infusion for patients with acute myeloid leukemia post allogeneic stem cell transplantation who are in complete remission but a thigh risk for relapse [Abstract]

Autor: Robert Zeiser, Christoph Schmid, Gheath Alatrash, Ron Ram, Yuan Wu, Hans-Jochen Jochen Weber, Stephanie Grzesiak, Lamis K. Eldjerou, Charles Craddock

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cd45a9ce86e52f3713d20a83e537026
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/99684

Zobrazit plný text záznamu

Siremadlin (HDM201) is well tolerated and demonstrates clinical activity in patients with acute myeloid leukemia who have relapsed after allogeneic stem cell transplantation: a subset analysis of safety and preliminary efficacy [Abstract]

Autor: Eytan M. Stein, Jörg Chromik, Cecilia Carpio, Rogier Mous, Jean-Jacques Kiladjian, Gheath Alatrash, Antonio Curti, Charles Craddock, Christoph Schmid, Robert Zeiser, Lamis K. Eldjerou, Hans-Jochen Jochen Weber, Claire Fabre, Jeffrey Scott, Daniel J. DeAngelo

Introduction: Siremadlin is an oral (PO), potent and selective 2 nd generation inhibitor of Murine Double Minute-2 (MDM2i), resulting in a p53-dependent anti-proliferative effect. Siremadlin has a well-characterized safety profile and encouraging sin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34d98cac7ad0d712d98cb00b3f052808
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/98649

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání